Fortunis Venture Capital

Fortunis Venture Capital is a London-based, impact-oriented venture firm deploying capital into tech-for-good companies across the UK regions, with healthcare exposure focused on medical devices and digital health. The firm positions itself around impact alongside financial return, supporting founders whose products address social or health outcomes in addition to commercial opportunity. Its broader regional emphasis means it engages with founders outside the traditional London ecosystem alongside London-based companies. Fortunis is not framed as an AI-specialist investor, and limited public information is available about its named investment partners and portfolio companies.

Fortunis invests at Seed and Series A stages, with checks in the $1M to $5M range, sized to lead or meaningfully participate in early institutional rounds. Geographic focus is the United Kingdom with explicit interest in regions outside London, reflecting the firm’s view that capital access is uneven across the country. The fund typically co-invests with regional angel networks, public-sector regional funds, and other UK early-stage venture firms.

For founders, Fortunis offers an early-stage partner that is genuinely receptive to companies headquartered outside London and that takes impact framing seriously. Founders should expect diligence to engage with both commercial fundamentals and impact narratives, with attention to evidence of outcomes alongside revenue. The firm is less suited to founders without a credible social or health impact thesis, or those raising large rounds beyond its check ceiling. For UK regional medtech and digital health entrepreneurs balancing commercial scale and meaningful impact, Fortunis is a relevant early-stage partner.